Liver disease in cystic fibrosis

Paediatric Respiratory Reviews

Volumn 15, Issue 1, 2014, Pages 69-74

  Leeuwen, Lisette ^a,b   Fitzgerald, Dominic A ^a,c   Gaskin, Kevin J ^a,c,d  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cholestasis; Cystic Fibrosis; Cystic Fibrosis associated Liver Disease; Liver transplantation; Morbidity; Mortality

Indexed keywords

CHILD; COMPLICATION; CYSTIC FIBROSIS; EARLY DIAGNOSIS; HEALTH; HUMAN; INCIDENCE; LIVER DISEASES; PROGNOSIS; RISK FACTOR;

CHILD; CYSTIC FIBROSIS; EARLY DIAGNOSIS; GLOBAL HEALTH; HUMANS; INCIDENCE; LIVER DISEASES; PROGNOSIS; RISK FACTORS;

EID: 84893908429     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2013.05.001     Document Type: Review

References (77)

1. Buzzetti R., Salvatore D., Baldo E., Forneris M.P., Lucidi V., Manunza D., et al. An overview of international literature from cystic fibrosis registries: 1. Mortality and survival studies in cystic fibrosis. J Cyst Fibros 2009, 8:229-237.
2. Cystic Fibrosis Canada. Canadian Cystic Fibrosis Patient Data Registry report, 2010. Available at. Accessed March, 2013. http://www.cysticfibrosis.ca/assets/files/pdf/cpdr_reporte.pdf.
3. Wilschanski M., Durie P.R. Patterns of GI disease in adulthood associated with mutations in the CFTR gene. Gut 2007, 56:1153-1163.
4. Sims E.J., McCormick J., Mehta G., Mehta A. Steering Committee of the UK Cystic Fibrosis Database. Neonatal screening for cystic fibrosis is beneficial even in the context of modern treatment. J Pediatr 2005, 147:S42-S46.
5. Dijk F.N., McKay K., Barzi F., Gaskin K.J., Fitzgerald D.A. Improved survival in cystic fibrosis patients diagnosed by newborn screening compared to a historical cohort from the same centre. Arch Dis Child 2011, 96:1118-1123.
6. Colombo C. Liver disease in cystic fibrosis. Curr Opin Pulm Med 2007, 13:529-536.
7. Pereira T.N., Walsh M.J., Lewindon P.J., Ramm G.A. Paediatric cholestatic liver disease: Diagnosis, assessment of disease progression and mechanisms of fibrogenesis. World J Gastrointest Pathophysiol 2010, 15:69-84.
8. Diwakar V., Pearson L., Beath S. Liver disease in children with cystic fibrosis. Paediatr Respir Rev 2001, 2:340-349.
9. Herrmann U., Dockter G., Lammert F. Cystic fibrosis-associated liver disease. Best Pract Res Clin Gastroenterol 2010, 24:585-592.
10. Flass T., Narkewicz M.R. Cirrhosis and other liver disease in cystic fibrosis. J Cyst Fibros 2013, 12:116-124.
11. Lykavieris P., Bernard O., Hadchouel M. Neonatal cholestasis as the presenting feature in cystic fibrosis. Arch Dis Child 1996, 75:67-70.
12. Shapira R., Hadzic N., Francavilla R., Koukulis G., Price J.F., Mieli-Vergani G. Retrospective review of cystic fibrosis presenting as infantile liver disease. Arch Dis Child 1999, 81:125-128.
13. Gaskin K.J., Waters D.L., Howman-Giles R., de Silva M., Earl J.W., Martin H.C., et al. Liver disease and common-bile-duct stenosis in cystic fibrosis. N Engl J Med 1988, 318:340-346.
14. Potter C.J., Fishbein M., Hammond S., McCoy K., Qualman S. Can the histologic changes of cystic fibrosis-associated hepatobiliary disease be predicted by clinical criteria?. J Pediatr Gastroenterol Nutr 1997, 25:32-36.
15. Lindblad A., Glaumann H., Strandvik B. Natural history of liver disease in cystic fibrosis. Hepatology 1999, 30:1151-1158.
16. Feranchak A.P. Hepatobiliary complications of cystic fibrosis. Curr Gastroenterol Rep 2004, 6:231-239.
17. Blanc W.A., Di Sant'Agnese P.A. A distinctive type of biliary cirrhosis of the liver associated with cystic fibrosis of the pancreas; recognition through signs of portal hypertension. Pediatrics 1956, 18:387-409.
18. Vawter G.F., Schwachman H. Cystic fibrosis in adults, an autopsy study. Pathol Annu 1979, 14:357-382.
19. Scott-Jupp R., Lama M., Tanner M.S. Prevalence of liver disease in cystic fibrosis. Arch Dis Child 1991, 66:698-701.
20. Feigelson J., Anagnostopoulos C., Poquet M., Pecau Y., Munck A., Navarro J. Liver cirrhosis in cystic fibrosis--therapeutic implications and long term follow up. Arch Dis Child 1993, 68:653-657.
21. Colombo C., Battezzati P.M., Crosignani A., Morabito A., Costantini D., Padoan R. Liver disease in cystic fibrosis: a prospective study on incidence, risk factors and outcome. Hepatology 2002, 36:1374-1382.
22. Slieker M.G., Deckers-Kocken J.M., Uiterwaal C.S., van der Ent C.K., Houwen R.H. Risk factors for the development of cystic fibrosis-related liver disease. Hepatology 2003, 38:775-776.
23. Chryssostalis A., Hubert D., Coste J., Kanaan R., Burgel P.R., Desmazes-Dufeu N., et al. Liver disease in adult patients with cystic fibrosis: a frequent and independent prognostic factor associated with death or lung transplantation. J Hepatol 2011, 55:1377-1382.
24. Wilschanski M., Rivlin J., Cohen S., Augarten A., Blau H., Aviram M., et al. Clinical and genetic risk factors for cystic fibrosis-related liver disease. Pediatrics 1999, 103:52-57.
25. Lamireau T., Monnereau S., Martin S., Marcotte J., Winnock M., Alvarez F. Epidemiology of liver disease in cystic fibrosis: a longitudinal study. J Hepatol 2004, 41:920-925.
26. Efrati O., Barak A., Modan-Moses D., Augarten A., Vilozni D., Katznelson D., et al. Liver cirrhosis and portal hypertension in cystic fibrosis. Eur J Gastroenterol Hepatol 2003, 15:1073-1078.
27. Rowland M., Gallagher C.G., O'Laoide R., Canny G., Broderick A., Hayes R., et al. Outcome in cystic fibrosis liver disease. Am J Gastroenterol 2011, 106:104-109.
28. Cohn J.A., Strong T.V., Picciotto M.R., Nairn A.C., Collins F.S., Fitz J.G. Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells. Gastroenterology 1993, 105:1857-1864.
29. Lamireau T., Zoltowska M., Levy E., Yousef I., Rosenbaum J., Tuchweber B., et al. Effects of bile acids on biliary epithelial cells: proliferation, cytotoxicity, and cytokine secretion. Life Sci 2003, 72:1401-1411.
30. Smith J.L., Lewindon P.J., Hoskins A.C., Pereira T.N., Setchell K.D.R., O'Connell N.C. Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis. Hepatology 2004, 39:1673-1682.
31. Ramm G.A., Shepherd R.W., Hoskins A.C., Greco S.A., Ney A.D., Pereira T.N., et al. Fibrogenesis in pediatric cholestatic liver disease: role of taurocholate and hepatocyte-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment. Hepatology 2009, 49:533-544.
32. Lewindon P.J., Pereira T.N., Hoskins A.C., Bridle K.R., Williamson R.M., Shepherd R.W., et al. The role of hepatic stellate cells and transforming growth factor-β1 in cystic fibrosis liver disease. Am J Pathol 2002, 160:1705-1715.
33. Debray D., Kelly D., Houwen R., Strandvik B., Colombo C. Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease. J Cyst Fibros 2011, 10:S29-S36.
34. Ling S.C., Wilkinson J.D., Hollman A.S., McColl J., Evans T.J., Paton J.Y. The evolution of liver disease in cystic fibrosis. Arch Dis Child 1999, 81:129-132.
35. Patriquin H., Lenaerts C., Smith L., Perreault G., Grignon A., Filiatrault D., et al. Liver disease in children with cystic fibrosis: US-biochemical comparison in 195 patients. Radiology 1999, 211:229-232.
36. Lenaerts C., Lapierre C., Patriquin H., Bureau N., Lepage G., Harel F., et al. Surveillance for cystic fibrosis-associated hepatobiliary disease: early ultrasound changes and predisposing factors. J Pediatr 2003, 143:343-350.
37. Mueller-Abt P.R., Frawley K.J., Greer R.M., Lewindon P.J. Comparison of ultrasound and biopsy findings in children with cystic fibrosis related liver disease. J Cyst Fibros 2008, 7:215-221.
38. Lewindon P.J., Shepherd R.W., Walsh M.J., Greer R.M., Williamson R., Pereira T.N., et al. Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy. Hepatology 2011, 53:193-201.
39. Witters P., De Boeck K., Dupont L., Proesmans M., Vermeulen F., Servaes R., et al. Non-invasive liver elastography (Fibroscan) for detection of cystic fibrosis-associated liver disease. J Cyst Fibros 2009, 8:392-399.
40. Colombo C., Battezzati P.M., Strazzabosco M., Podda M. Liver and biliary problems in cystic fibrosis. Semin Liver Dis 1998, 18:227-235.
41. Debray D., Lykavieris P., Gauthier F., Dousset B., Sardet A., Munck A., et al. Outcome of cystic fibrosis-associated liver cirrhosis: management of portal hypertension. J Hepatol 1999, 31:77-83.
42. Corbett K., Kelleher S., Rowland M., Daly L., Drumm B., Canny G., et al. Cystic fibrosis-associated liver disease: a population-based study. J Pediatr 2004, 145:327-332.
43. Sokol R.J., Durie P.R. Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group. J Pediatr Gastroenterol Nutr 1999, 28:S1-S13.
44. Minicucci L., Lorini R., Giannattasio A., Colombo C., Iapichino L., Reali M.F., et al. Liver disease as risk factor for cystic-fibrosis-related diabetes development. Acta Paediatr 2007, 96:736-739.
45. Gooding I., Dondos V., Gyi K.M., Hodson M., Westaby D. Variceal hemorrhage and cystic fibrosis: outcomes and implications for liver transplantation. Liver Transpl 2005, 11:1522-1526.
46. Collaco J.M., Cutting G.R. Update on gene modifiers in cystic fibrosis. Curr Opin Pulm Med 2008, 14:559-566.
47. Bartlett J.R., Friedman K.J., Ling S.C., Pace R.G., Bell S.C., Bourke B., et al. Genetic modifiers of liver disease in cystic fibrosis. JAMA 2009, 302:1076-1083.
48. Colombo C., Apostolo M.G., Ferrari M., Seia M., Genoni S., Giunta A., et al. Analysis of risk factors for the development of liver disease associated with cystic fibrosis. J Pediatr 1994, 124:393-399.
49. Maurage C., Lenaerts C., Weber A., Brochu P., Yousef I., Roy C.C. Meconium ileus and its equivalent as a risk factor for the development of cirrhosis: an autopsy study in cystic fibrosis. J Pediatr Gastroenterol Nutr 1989, 9:17-20.
50. Feranchak A.P., Sokol R.J. Cholangiocyte biology and cystic fibrosis liver disease. Semin Liver Dis 2001, 21:471-488.
51. Paumgartner G., Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology 2002, 36:525-531.
52. Beuers U. Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat Clin Pract Gastroenterol Hepatol 2006, 3:318-328.
53. Roma M.G., Toledo F.D., Boaglio A.C., Basiglio C.L., Crocenzi F.A., Sánchez Pozzi E.J. Ursodeoxycholic acid in cholestasis: linking mechanisms to therapeutic actions. Clin Sci (Lond) 2011, 121:523-544.
54. Galabert C., Montet J.C., Lengrand D., Lecuire A., Sotta C., Figarella C., et al. Effects of ursodeoxycholic acid on liver function in patients with cystic fibrosis and chronic cholestasis. J Pediatr 1992, 121:138-141.
55. Colombo C., Battezzati P.M., Podda M., Bettinardi N., Giunta A. Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis. Hepatology 1996, 23:1484-1490.
56. O'Brien S.M., Campbell G.R., Burke A.F., Maguire O.C., Rowlands B.J., FitzGerald M.X., et al. Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease. Eur J Gastroenterol Hepatol 1996, 8:477-483.
57. Lindblad A., Glaumann H., Strandvik B. A two-year prospective study of the effect of ursoedoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease. Hepatology 1998, 27:166-174.
58. Nousia-Arvanitakis S., Fotoulaki M., Economou H., Xefteri M., Galli-Tsinopoulou A. Long-term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis-related liver disease. J Clin Gastrenterol 2001, 32:324-328.
59. Desmond C.P., Wilson J., Bailey M., Clark D., Roberts S.K. The benign course of liver disease in adults with cystic fibrosis and the effect of ursodeoxycholic acid. Liver Int 2007, 27:1402-1408.
60. Cheng K., Ashby D., Smyth R.L. Ursodeoxycholic acid for cystic fibrosis-related liver disease. Cochrane Database Syst Rev 2012, 10. CD000222.
61. Mileti E., Rosenthal P. Management of portal hypertension in children. Curr Gastroenterol Rep 2011, 13:10-16.
62. Melzi M.L., Kelly D.A., Colombo C., Jara P., Manzanares J., Colledan M., et al. Liver transplant in cystic fibrosis: a poll among European centers. A study from the European Liver Transplant Registry. Transpl Int 2006, 19:726-731.
63. Mendizabal M., Reddy K.R., Cassuto J., Olthoff K.M., Faust T.W., Makar G.A., et al. Liver transplantation in patients with cystic fibrosis: analysis of United Network for Organ Sharing data. Liver Transpl 2011, 17:243-250.
64. Lu B.R., Esquivel C.O. A review of abdominal organ transplantation in cystic fibrosis. Pediatr Transplant 2010, 14:954-960.
65. Mack D.R., Traystman M.D., Colombo J.L., Sammut P.H., Kaufman S.S., Vanderhoof J.A., et al. Clinical denouement and mutation analysis of patients with cystic fibrosis undergoing liver transplantation for biliary cirrhosis. J Pediatr 1995, 127:881-887.
66. Noble-Jamieson G., Barnes N., Jamieson N., Friend P., Calne R. Liver transplantation for hepatic cirrhosis in cystic fibrosis. J R Soc Med 1996, 89:31-37.
67. Milkiewicz P., Skiba G., Kelly D., Weller P., Bonser R., Gur U., et al. Transplantation for cystic fibrosis: outcome following early liver transplantation. J Gastroenterol Hepatol 2002, 17:208-213.
68. Fridell J.A., Bond G.J., Mazariegos G.V., Orenstein D.M., Jain A., Sindhi R., et al. Liver transplantation in children with cystic fibrosis: a long-term longitudinal review of a single center's experience. J Pediatr Surg 2003, 38:1152-1156.
69. Colombo C., Costantini D., Rocchi A., Romano G., Rossi G., Bianchi M.L., et al. Effects of liver transplantation on the nutritional status of patients with cystic fibrosis. Transpl Int 2005, 18:246-255.
70. Nightingale S., O'Loughlin E.V., Dorney S.F., Shun A., Verran D.J., Strasser S.I., et al. Isolated liver transplantation in children with cystic fibrosis--an Australian experience. Pediatr Transplant 2010, 14:779-785.
71. Dowman J.K., Watson D., Loganathan S., Gunson B.K., Hodson J., Mirza D.F., et al. Long-term impact of liver transplantation on respiratory function and nutritional status in children and adults with cystic fibrosis. Am J Transplant 2012, 12:954-964.
72. Nash K.L., Allison M.E., McKeon D., Lomas D.J., Haworth C.S., Bilton D., et al. A single centre experience of liver disease in adults with cystic fibrosis 1995-2006. J Cyst Fibros 2008, 7:252-257.
73. Miller M.R., Sokol R.J., Narkewicz M.R., Sontag M.K. Pulmonary function in individuals who underwent liver transplantation: from the US cystic fibrosis foundation registry. Liver Transpl 2012, 18:585-593.
74. Genyk Y.S., Quiros J.A., Jabbour N., Selby R.R., Thomas D.W. Liver transplantation in cystic fibrosis. Curr Opin Pulm Med 2001, 7:441-447.
75. Molmenti E.P., Squires R.H., Nagata D., Roden J.S., Molmenti H., Fasola C.G., et al. Liver transplantation for cholestasis associated with cystic fibrosis in the pediatric population. Pediatr Transplant 2003, 7:93-97.
76. Jonas M.M. The role of liver transplantation in cystic fibrosis re-examined. Liver Transpl 2005, 11:1463-1465.
77. Arnon R., Annunziato R.A., Miloh T., Padilla M., Sogawa H., Batemarco L., et al. Liver and combined lung and liver transplantation for cystic fibrosis: analysis of the UNOS database. Pediatr Transplant 2011, 15:254-264.